CVE-2025-30726

Description

Vulnerability in the Oracle Application Object Library product of Oracle E-Business Suite (component: Core). Supported versions that are affected are 12.2.3-12.2.14. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Application Object Library. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Application Object Library accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Category

5.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.04%
Vendor Advisory oracle.com
Affected: Oracle Corporation Oracle Application Object Library
Published at:
Updated at:

References

Link Tags
https://www.oracle.com/security-alerts/cpuapr2025.html patch vendor advisory

Frequently Asked Questions

What is the severity of CVE-2025-30726?
CVE-2025-30726 has been scored as a medium severity vulnerability.
How to fix CVE-2025-30726?
To fix CVE-2025-30726, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-30726 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-30726 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-30726?
CVE-2025-30726 affects Oracle Corporation Oracle Application Object Library.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.